BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Z, Chen Q, Zhang W, Si G, Li J, Jiao D, Han X. Efficacy and Safety of the Arsenic Trioxide/Lipiodol Emulsion in the Transcatheter Arterial Chemoembolization Combined with Apatinib in the Treatment of Advanced Hepatocellular Carcinoma. Can J Gastroenterol Hepatol 2021;2021:5565793. [PMID: 34458205 DOI: 10.1155/2021/5565793] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang H, Liu D, Wang C, Yu S, Jin G, Wang C, Zhang B, Zhang D, Shao D. Transarterial chemoembolization (TACE) plus apatinib-combined therapy versus TACE alone in the treatment of intermediate to advanced hepatocellular carcinoma patients: A real-world study. Clin Res Hepatol Gastroenterol 2022;46:101869. [PMID: 35108656 DOI: 10.1016/j.clinre.2022.101869] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 . Rivoceranib. Reactions Weekly 2022;1908:497-497. [DOI: 10.1007/s40278-022-16225-2] [Reference Citation Analysis]
3 Ouyang T, Liu J, Shi C, Zhu L, Guo X. Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study. J Hepatocell Carcinoma 2021;8:1459-71. [PMID: 34858890 DOI: 10.2147/JHC.S338309] [Cited by in F6Publishing: 1] [Reference Citation Analysis]